eFFECTOR Therapeutics- Warrants (26/08/2026) OvervieweFFECTOR Therapeutics- Warrants (26/08/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for EFTRW.
Quarterly EBIT
-$185.84K
↓ 293.84% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$320.19K
↑ 99.03% YoY
Trailing 12 months ending Mar 31, 2026